Document is current

Article History

Received: 17 December 2024

Revised: 11 February 2025

Accepted: 7 April 2025

First Online: 1 May 2025

Compliance with ethical standards

:

: The scientific guarantor of this publication is Prof. Benedikt Schaarschmidt.

: The authors of this manuscript declare relationships with the following companies: S.U. declares research support from Bristol Myers Squibb and Merck Serono; speakers and advisory board honoraria from Bristol Myers Squibb, Merck Sharp & Dohme, Merck Serono, and Novartis; and meeting and travel support from Almirall, Bristol Myers Squibb, IGEA Clinical Biophysics, Merck Sharp & Dohme, Novartis, Pierre Fabre, and Sun Pharma; outside the submitted work. L.Z. served as consultant and has received honoraria from BMS, MSD, Novartis, Pierre Fabre, Sanofi, and Sun Pharma and travel support from MSD, BMS, Pierre Fabre, Sanofi, Sun Pharma and Novartis, outside the submitted work. The remaining authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

: No complex statistical methods were necessary for this paper.

: Written informed consent was waived by the Institutional Review Board.

: Institutional Review Board approval was obtained.

: None.

: